A former clinical research company employee may proceed with claims her employer fired her for reporting alleged research misconduct to the Food and Drug Administration, a federal court in Connecticut said.
Meredith Bacewicz stated a claim for retaliation under the False Claims Act and Connecticut law when she alleged Molecular Neuroimaging LLC terminated her for investigating and reporting conduct that could have led to the filing of an FCA claim, the U.S. District Court for the District of Connecticut said Sept. 23.
MNI provides services related to clinical research studies and drug development for neurodegenerative and neuropsychiatric disorders. It conducts ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.